Corifollitropin alfa followed by hpHMG in GnRH agonist protocols. Two prospective feasibility studies in poor ovarian responders
暂无分享,去创建一个
H. Tournaye | M. Camus | P. Humaidan | P. Drakopoulos | N. Polyzos | C. Blockeel | M. De Vos | R. Corona | A. van de Vijver | V. Vloeberghs